Biotech & Pharma Consulting
Alacrita provides strategic expertise, specialized analysis, and hands-on execution to help life science companies, investors, and academic institutions make critical decisions and advance R&D and business objectives, across each stage of drug development.
Our consultants have led programs discovering, developing, manufacturing, and commercializing drug products, bringing the practical insight and execution expertise that only come from having done the work themselves. Our core team draws on a network of more than 350 experienced specialists across 29 functional disciplines, brought into projects when their expertise is directly relevant. This model allows us to assemble the right team quickly, stay adaptable as projects evolve, and provide precisely relevant support at the level each client requires.
We support clients across three core areas: product development, enterprise development, and business development.
For more than fifteen years, we've helped life-science organizations solve complex scientific and operational challenges, make critical business and investment decisions, strengthen leadership capacity, and advance their programs with the rigor and judgment of experienced industry professionals and the agility to adapt as needs evolve.
How China's streamlined drug approval reforms are pressuring major markets to rethink regulatory strategy, with far-reaching implications for global development.
Read AnalysisThe difference between theoretical knowledge and practical execution often comes down to experience. When you're facing critical decisions in drug development or business strategy, you need consultants who have actually solved similar challenges before.
That's exactly what our model delivers. Our core team works alongside network specialists to provide integrated solutions that align with your business reality and program goals. We provide both strategic guidance and hands-on execution support, translating specialized expertise into practical outcomes that fit your timeline, budget, and risk tolerance.
Our expert teams are ready to support you through every step of product development, making sure you maximize value at each stage.
Gauge and rank the commercial potential of your R&D programs or technology platforms by framing market opportunities and charting the optimal path to value creation.
Learn about opportunity mappingAccelerate your early-stage programs with strategic, technical and regulatory expertise to navigate complex development challenges and achieve IND readiness efficiently.
Explore preclinical servicesLeverage seasoned drug development physicians to design robust clinical strategies, optimize trial operations, and advance programs through regulatory milestones.
Discover clinical servicesComprehensive regulatory strategy and submission support to navigate complex approval processes efficiently.
Learn about regulatory servicesChemistry, manufacturing, and controls expertise to support drug development and regulatory submissions.
Explore CMC servicesProvided critical support for early-stage biotech's two lead AAV-delivered gene therapy programs, including preclinical development planning, CMC roadmap, and regulatory strategy to IND.
Read case studySupported small biotech through peptide development including manufacture, analytical methods, formulation strategy and MHRA meetings for Phase I trials.
Read case studyWe help biotech companies build the strategic and operational foundations needed to advance and fund their programs. From specialized functional expertise across 29 disciplines to business planning and platform strategy, Alacrita brings experienced industry consultants who provide strategic guidance, hands-on execution support, and operational continuity through key inflection points.
Crafting investor-ready business plans and fundraising narratives that withstand diligence and give investors the clarity needed to commit capital with confidence.
Learn about fundraising supportBridge leadership gaps with seasoned operators who provide continuity, credibility, and execution support to keep virtual programs focused and capital efficient.
Find out about CMO servicesGuiding platform developers through critical decisions on partnerships, business models, and regulatory pathways to link near-term data packages with long-term value creation.
Explore platform strategyMapping strategic requirements, resources, and timelines for commercializing pipeline products to inform critical early-stage decisions with future market clarity.
Explore launch planningDeveloped comprehensive business plan and fundraising materials for early-stage gene therapy company, supporting successful capital raise.
Read case studyMedical oncologist with 25+ years experience integrated as interim CMO to guide early-stage biotech through IND submission and clinical development strategy.
Read case studyWe dovetail with your in-house business development team to help find, evaluate and assess new assets, even taking responsibility for out-licensing your products to a pharma partner.
Discovering and evaluating promising therapeutic opportunities aligned with your strategic objectives to maximize deal-sourcing effectiveness and partnership potential.
Learn about asset scoutingDelivering comprehensive technical and commercial assessments that provide complete, accurate analysis for confident partnership and investment decisions.
Discover due diligence servicesDeveloping robust valuation models with clear alignment between transaction price and asset value to inform strategic decision-making and investments.
Explore valuation servicesNavigate complex licensing negotiations with tailored support for both buy and sell-side transactions to ensure optimal deal structures and terms.
Learn about deal-makingBridge the gap between academic research and commercial applications with specialized expertise to maximize technology transfer value and partnership opportunities.
Explore commercialization servicesConducted due diligence on a series of investments in oncology and genetic diseases, providing comprehensive technical and commercial assessments for investment decisions.
Read case studyConducted comprehensive analysis of comparable licensing deals for clinical stage ophthalmic disease company considering partnership of lead asset across three deal scenarios.
Read case studyStrategic, scientific, and operational expertise to support life science investors, guide biotech fundraising, and accelerate value across the investment lifecycle.
Supporting biotech companies through fundraising and post-investment execution with integrated strategic, technical, and operational expertise to strengthen investor readiness and maximize value at each milestone.
Learn about fundraising supportPartnering with venture firms to enhance diligence, accelerate evaluation, and provide hands-on execution support to portfolio companies across scientific assessment, valuation modeling, and post-investment operational guidance.
Explore VC advisorySupporting IR teams and executive leadership with scientific and strategic depth to strengthen investor engagement, milestone communications, and credible narrative development across the fundraising lifecycle.
Discover IR supportConducted due diligence for investor considering re-investing into development-stage microbiome company, evaluating clinical trial feasibility and manufacturing scale-up capacity.
Read case studyProvided technical and market due diligence for private equity investor evaluating acquisition of fast-growing chemistry CRO providing custom synthesis services.
Read case studyAlacrita's core team and extensive network of independent, specialist consultants provide law firms with expert witnesses who have the precise technical or commercial expertise required for the needs of their case.
Retained by law firm to provide expert input on dispute between two large pharma companies on the subject and terms of historical licensing deal and royalty payment terms.
Read case studyProvided expert witness to support litigation process between major global law firm's client and another Big Pharma company, with deep experience in the relevant technology domain.
Read case studyReal-world examples of how our expertise has helped clients achieve their objectives.
Challenge: A private equity investor was considering a transaction in a fast-growing chemistry CRO providing custom synthesis and process development chemistry services. The PE investor commissioned Alacrita to conduct in-depth technical and market due diligence.
Read full case studyChallenge: An early-stage biotech developing a targeted cancer therapy engaged Alacrita to provide expertise to help them navigate an upcoming IND submission and clinical development strategy.
Read full case studyChallenge: An investor was considering re-investing into a development-stage microbiome company that had experienced issues delaying timelines. They were concerned about the feasibility of completing remaining clinical trials and capacity to scale up GMP manufacturing for potential commercial launch.
Read full case studyChallenge: A research-based biotech needed a clear understanding of the processes, resources and timelines to establish a global pharma supply chain for their leading pipeline compound, a therapy for an ultra-rare immunological disease.
Read full case studyChallenge: A small, Swiss-based biotech with a pre-commercial pipeline of therapeutic antibodies for rare and ultra-rare diseases was preparing to launch its first asset and needed advice on transitioning from a research-focused organization to a global, commercial company.
Read full case studyChallenge: Alacrita was retained by a law firm to provide expert input on a dispute between two large pharma companies on the subject and terms of a historical licensing deal and the term for which royalties were payable on a market leading drug.
Read full case studyAlacrita brings together world-class biotech consultants from the upper echelon of the pharmaceutical industry. Every member of our team and our supporting network, have been carefully selected, to ensure we’re offering our clients only the highest-level of expertise available.
Whether your life science organization is a rapidly growing biotech needing specific expertise to forge ahead now, an established pharma company seeking to augment existing capabilities in the short-term, or a healthcare investor looking to assess risk and evaluate future returns, our consultants can support you in reaching your goal.
Speak with us about our pharma & biotech consulting services.
Alacrita Consulting, Limited
UK, Europe & Asia
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
Alacrita Consulting, Inc.
US
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Delaware
© 2009 - 2025 Alacrita Holdings Limited
